XML 65 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Investments (Tables)
12 Months Ended
Dec. 31, 2023
Investments [Abstract]  
Schedule of Investments The following table sets forth the Company’s investments:
 

December 31, 2023

 

December 31, 2022

   

Carrying
Value

 

Cost

 

Carrying
Value

 

Cost

Securrency, Inc.:

               

Series A Shares

 

$

 

$

 

$

8,488

 

$

8,112

Series B Shares

 

 

 

 

 

 

5,500

 

 

5,500

Convertible note

 

 

 

 

 

 

14,500

 

 

15,000

Subtotal—Securrency, Inc.

 

 

 

 

 

 

28,488

 

 

28,612

Fnality International Limited:

 

 

   

 

   

 

   

 

 

Convertible note

 

 

 

 

 

 

6,921

 

 

6,863

Series B-1 Preference Shares

 

 

9,684

 

 

8,091

 

 

 

 

Subtotal—Fnality International Limited

 

 

9,684

 

 

8,091

 

 

6,921

 

 

6,863

Other investments

 

 

 

 

250

 

 

312

 

 

250

Total

 

$

9,684

 

$

8,341

 

$

35,721

 

$

35,725

Schedule of Backsolve Valuation Approach The table below presents the inputs used in the backsolve valuation approach (classified as Level 3 in the fair value hierarchy):
 

Inputs

   

June 9,
2021

 

March 8,
2021

Expected volatility

 

50%

 

55%

Time to exit (in years)

 

4.75

 

5.00

 

December 31,
2023

Expected volatility

 

60%

Time to exit (in years)

 

5.00

Probability that Series B-2 Preference Shares convert into Series B-1 Preference Shares

 

75%

Schedule of Presents the Probability Ascribed to Potential Outcomes Used in the Pwerm The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:
 

December 31,
2022

Conversion of note upon a future equity financing

 

60%

Redemption of note upon a corporate transaction

 

25%

Default

 

15%

Time to potential outcome (in years)

 

0.33

 

December 31,
2022

Conversion of note upon a future financing round

 

85%

Redemption of note upon a change of control

 

10%

Default

 

5%

Time to potential outcome (in years)

 

0.25